Biodesix to showcase new data on patient immune profiling from multiple studies at world lung conference

Boulder, colo.--(business wire)--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that three abstracts from multiple clinical studies will be featured at the international association for the study of lung cancer (iaslc) world conference on lung cancer (wclc), scheduled for january 28-31, 2021. findings from these recent studies demonstrate that an individual patient's immune profile can provide information to suppor
BDSX Ratings Summary
BDSX Quant Ranking